glp 1 study Different GLP-1 therapies could be tailored to different needs Study finds GLP-1 receptor agonists

Losing weight helps reduce what used to be called non-alcoholic fatty liver disease and is now known as metabolic dysfunction-associated steatotic liver disease or MASLD

In addition, liraglutide provided multiple additional benefits by reducing the incidence of hypoglycemia, lowering HbA1c and functioning through multiple mechanisms to better control multiple causes of MACE, such as blood lipids, BP as well as body weight (BW)

This leads to increase in gastric volumes and putting the patients at increased risk of aspiration during sedation (107)

This means you must have these nutrients present to absorb them

Don and I liked Sarahs point about nutrition with this